ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Clostridium Butyricum Powder Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-21G18228
Home | Market Reports | Science| Biological Sciences
Global Clostridium Butyricum Powder Market Research Report 2024
BUY CHAPTERS

Global Clostridium Butyricum Powder Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-21G18228
Report
October 2025
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Miyarisan Pharmaceutical
Toa Pharmaceutical
Shan Dong Kexing Biopharm
Qingdao Eastsea Pharmaceutical

Clostridium Butyricum Powder Market

The global Clostridium Butyricum Powder market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Clostridium Butyricum Preparation is a white or gray powder preparation containing highly active Clostridium butyricum. Clostridium butyricum is a strictly anaerobic endospore-forming Gram-positive butyric acid–producing bacillus subsisting by means of fermentation using an intracellularly accumulated amylopectin-like α-polyglucan (granulose) as a substrate.
From a downstream perspective, Online Sales accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Clostridium Butyricum Powder leading manufacturers including Miyarisan Pharmaceutical, Toa Pharmaceutical, Shan Dong Kexing Biopharm, Qingdao Eastsea Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Miyarisan Pharmaceutical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Clostridium Butyricum Powder market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Clostridium Butyricum Powder Market Report

Report Metric Details
Report Name Clostridium Butyricum Powder Market
Segment by Type
  • Single Clostridium Butyricum Powder
  • Compound Clostridium Butyricum Powder
Segment by Application
  • Online Sales
  • Offline Sales
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Miyarisan Pharmaceutical, Toa Pharmaceutical, Shan Dong Kexing Biopharm, Qingdao Eastsea Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Clostridium Butyricum Powder study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Clostridium Butyricum Powder Market report?

Ans: The main players in the Clostridium Butyricum Powder Market are Miyarisan Pharmaceutical, Toa Pharmaceutical, Shan Dong Kexing Biopharm, Qingdao Eastsea Pharmaceutical

What are the Application segmentation covered in the Clostridium Butyricum Powder Market report?

Ans: The Applications covered in the Clostridium Butyricum Powder Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Clostridium Butyricum Powder Market report?

Ans: The Types covered in the Clostridium Butyricum Powder Market report are Single Clostridium Butyricum Powder, Compound Clostridium Butyricum Powder

1 Study Coverage
1.1 Introduction to Clostridium Butyricum Powder: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Clostridium Butyricum Powder Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single Clostridium Butyricum Powder
1.2.3 Compound Clostridium Butyricum Powder
1.3 Market Segmentation by Application
1.3.1 Global Clostridium Butyricum Powder Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Clostridium Butyricum Powder Revenue Estimates and Forecasts 2020-2031
2.2 Global Clostridium Butyricum Powder Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Clostridium Butyricum Powder Sales Estimates and Forecasts 2020-2031
2.4 Global Clostridium Butyricum Powder Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Clostridium Butyricum Powder Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Clostridium Butyricum Powder Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Single Clostridium Butyricum Powder Market Size by Manufacturers
3.5.2 Compound Clostridium Butyricum Powder Market Size by Manufacturers
3.6 Global Clostridium Butyricum Powder Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Clostridium Butyricum Powder Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Clostridium Butyricum Powder Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Clostridium Butyricum Powder Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Clostridium Butyricum Powder Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Clostridium Butyricum Powder Sales and Revenue by Type (2020-2031)
6.4 North America Clostridium Butyricum Powder Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Clostridium Butyricum Powder Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Clostridium Butyricum Powder Sales and Revenue by Type (2020-2031)
7.4 Europe Clostridium Butyricum Powder Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Clostridium Butyricum Powder Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Clostridium Butyricum Powder Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Clostridium Butyricum Powder Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Clostridium Butyricum Powder Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Clostridium Butyricum Powder Sales and Revenue by Type (2020-2031)
9.4 Central and South America Clostridium Butyricum Powder Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Clostridium Butyricum Powder Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Clostridium Butyricum Powder Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Clostridium Butyricum Powder Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Clostridium Butyricum Powder Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Miyarisan Pharmaceutical
11.1.1 Miyarisan Pharmaceutical Corporation Information
11.1.2 Miyarisan Pharmaceutical Business Overview
11.1.3 Miyarisan Pharmaceutical Clostridium Butyricum Powder Product Models, Descriptions and Specifications
11.1.4 Miyarisan Pharmaceutical Clostridium Butyricum Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Miyarisan Pharmaceutical Clostridium Butyricum Powder Sales by Product in 2024
11.1.6 Miyarisan Pharmaceutical Clostridium Butyricum Powder Sales by Application in 2024
11.1.7 Miyarisan Pharmaceutical Clostridium Butyricum Powder Sales by Geographic Area in 2024
11.1.8 Miyarisan Pharmaceutical Clostridium Butyricum Powder SWOT Analysis
11.1.9 Miyarisan Pharmaceutical Recent Developments
11.2 Toa Pharmaceutical
11.2.1 Toa Pharmaceutical Corporation Information
11.2.2 Toa Pharmaceutical Business Overview
11.2.3 Toa Pharmaceutical Clostridium Butyricum Powder Product Models, Descriptions and Specifications
11.2.4 Toa Pharmaceutical Clostridium Butyricum Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Toa Pharmaceutical Clostridium Butyricum Powder Sales by Product in 2024
11.2.6 Toa Pharmaceutical Clostridium Butyricum Powder Sales by Application in 2024
11.2.7 Toa Pharmaceutical Clostridium Butyricum Powder Sales by Geographic Area in 2024
11.2.8 Toa Pharmaceutical Clostridium Butyricum Powder SWOT Analysis
11.2.9 Toa Pharmaceutical Recent Developments
11.3 Shan Dong Kexing Biopharm
11.3.1 Shan Dong Kexing Biopharm Corporation Information
11.3.2 Shan Dong Kexing Biopharm Business Overview
11.3.3 Shan Dong Kexing Biopharm Clostridium Butyricum Powder Product Models, Descriptions and Specifications
11.3.4 Shan Dong Kexing Biopharm Clostridium Butyricum Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Shan Dong Kexing Biopharm Clostridium Butyricum Powder Sales by Product in 2024
11.3.6 Shan Dong Kexing Biopharm Clostridium Butyricum Powder Sales by Application in 2024
11.3.7 Shan Dong Kexing Biopharm Clostridium Butyricum Powder Sales by Geographic Area in 2024
11.3.8 Shan Dong Kexing Biopharm Clostridium Butyricum Powder SWOT Analysis
11.3.9 Shan Dong Kexing Biopharm Recent Developments
11.4 Qingdao Eastsea Pharmaceutical
11.4.1 Qingdao Eastsea Pharmaceutical Corporation Information
11.4.2 Qingdao Eastsea Pharmaceutical Business Overview
11.4.3 Qingdao Eastsea Pharmaceutical Clostridium Butyricum Powder Product Models, Descriptions and Specifications
11.4.4 Qingdao Eastsea Pharmaceutical Clostridium Butyricum Powder Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Qingdao Eastsea Pharmaceutical Clostridium Butyricum Powder Sales by Product in 2024
11.4.6 Qingdao Eastsea Pharmaceutical Clostridium Butyricum Powder Sales by Application in 2024
11.4.7 Qingdao Eastsea Pharmaceutical Clostridium Butyricum Powder Sales by Geographic Area in 2024
11.4.8 Qingdao Eastsea Pharmaceutical Clostridium Butyricum Powder SWOT Analysis
11.4.9 Qingdao Eastsea Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Clostridium Butyricum Powder Industry Chain
12.2 Clostridium Butyricum Powder Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Clostridium Butyricum Powder Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Clostridium Butyricum Powder Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Clostridium Butyricum Powder Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Clostridium Butyricum Powder Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Miyarisan Pharmaceutical
Toa Pharmaceutical
Shan Dong Kexing Biopharm
Qingdao Eastsea Pharmaceutical
List of Tables
 Table 1. Global Clostridium Butyricum Powder Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Clostridium Butyricum Powder Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Clostridium Butyricum Powder Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Clostridium Butyricum Powder Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Clostridium Butyricum Powder Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Clostridium Butyricum Powder Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Clostridium Butyricum Powder Sales by Region (2020-2025) & (K Units)
 Table 8. Global Clostridium Butyricum Powder Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Clostridium Butyricum Powder Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Clostridium Butyricum Powder Sales Share by Manufacturers (2020-2025)
 Table 12. Global Clostridium Butyricum Powder Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Clostridium Butyricum Powder Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Clostridium Butyricum Powder by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clostridium Butyricum Powder as of 2024)
 Table 16. Global Clostridium Butyricum Powder Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Clostridium Butyricum Powder Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Clostridium Butyricum Powder Manufacturing Base and Headquarters
 Table 19. Global Clostridium Butyricum Powder Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Clostridium Butyricum Powder Sales by Type (2020-2025) & (K Units)
 Table 23. Global Clostridium Butyricum Powder Sales by Type (2026-2031) & (K Units)
 Table 24. Global Clostridium Butyricum Powder Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Clostridium Butyricum Powder Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Clostridium Butyricum Powder ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Clostridium Butyricum Powder Sales by Application (2020-2025) & (K Units)
 Table 29. Global Clostridium Butyricum Powder Sales by Application (2026-2031) & (K Units)
 Table 30. Clostridium Butyricum Powder High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Clostridium Butyricum Powder Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Clostridium Butyricum Powder Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Clostridium Butyricum Powder ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Clostridium Butyricum Powder Growth Accelerators and Market Barriers
 Table 37. North America Clostridium Butyricum Powder Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Clostridium Butyricum Powder Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Clostridium Butyricum Powder Growth Accelerators and Market Barriers
 Table 40. Europe Clostridium Butyricum Powder Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Clostridium Butyricum Powder Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Clostridium Butyricum Powder Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Clostridium Butyricum Powder Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Clostridium Butyricum Powder Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Clostridium Butyricum Powder Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Clostridium Butyricum Powder Investment Opportunities and Key Challenges
 Table 47. Central and South America Clostridium Butyricum Powder Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Clostridium Butyricum Powder Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Clostridium Butyricum Powder Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Miyarisan Pharmaceutical Corporation Information
 Table 51. Miyarisan Pharmaceutical Description and Major Businesses
 Table 52. Miyarisan Pharmaceutical Product Models, Descriptions and Specifications
 Table 53. Miyarisan Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Miyarisan Pharmaceutical Sales Value Proportion by Product in 2024
 Table 55. Miyarisan Pharmaceutical Sales Value Proportion by Application in 2024
 Table 56. Miyarisan Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 57. Miyarisan Pharmaceutical Clostridium Butyricum Powder SWOT Analysis
 Table 58. Miyarisan Pharmaceutical Recent Developments
 Table 59. Toa Pharmaceutical Corporation Information
 Table 60. Toa Pharmaceutical Description and Major Businesses
 Table 61. Toa Pharmaceutical Product Models, Descriptions and Specifications
 Table 62. Toa Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Toa Pharmaceutical Sales Value Proportion by Product in 2024
 Table 64. Toa Pharmaceutical Sales Value Proportion by Application in 2024
 Table 65. Toa Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 66. Toa Pharmaceutical Clostridium Butyricum Powder SWOT Analysis
 Table 67. Toa Pharmaceutical Recent Developments
 Table 68. Shan Dong Kexing Biopharm Corporation Information
 Table 69. Shan Dong Kexing Biopharm Description and Major Businesses
 Table 70. Shan Dong Kexing Biopharm Product Models, Descriptions and Specifications
 Table 71. Shan Dong Kexing Biopharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Shan Dong Kexing Biopharm Sales Value Proportion by Product in 2024
 Table 73. Shan Dong Kexing Biopharm Sales Value Proportion by Application in 2024
 Table 74. Shan Dong Kexing Biopharm Sales Value Proportion by Geographic Area in 2024
 Table 75. Shan Dong Kexing Biopharm Clostridium Butyricum Powder SWOT Analysis
 Table 76. Shan Dong Kexing Biopharm Recent Developments
 Table 77. Qingdao Eastsea Pharmaceutical Corporation Information
 Table 78. Qingdao Eastsea Pharmaceutical Description and Major Businesses
 Table 79. Qingdao Eastsea Pharmaceutical Product Models, Descriptions and Specifications
 Table 80. Qingdao Eastsea Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Qingdao Eastsea Pharmaceutical Sales Value Proportion by Product in 2024
 Table 82. Qingdao Eastsea Pharmaceutical Sales Value Proportion by Application in 2024
 Table 83. Qingdao Eastsea Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 84. Qingdao Eastsea Pharmaceutical Clostridium Butyricum Powder SWOT Analysis
 Table 85. Qingdao Eastsea Pharmaceutical Recent Developments
 Table 86. Key Raw Materials Distribution
 Table 87. Raw Materials Key Suppliers
 Table 88. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 89. Milestones in Production Technology Evolution
 Table 90. Distributors List
 Table 91. Market Trends and Market Evolution
 Table 92. Market Drivers and Opportunities
 Table 93. Market Challenges, Risks, and Restraints
 Table 94. Research Programs/Design for This Report
 Table 95. Key Data Information from Secondary Sources
 Table 96. Key Data Information from Primary Sources


List of Figures
 Figure 1. Clostridium Butyricum Powder Product Picture
 Figure 2. Global Clostridium Butyricum Powder Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Single Clostridium Butyricum Powder Product Picture
 Figure 4. Compound Clostridium Butyricum Powder Product Picture
 Figure 5. Global Clostridium Butyricum Powder Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Online Sales
 Figure 7. Offline Sales
 Figure 8. Clostridium Butyricum Powder Report Years Considered
 Figure 9. Global Clostridium Butyricum Powder Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Clostridium Butyricum Powder Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Clostridium Butyricum Powder Revenue Market Share by Region (2020-2031)
 Figure 13. Global Clostridium Butyricum Powder Sales (2020-2031) & (K Units)
 Figure 14. Global Clostridium Butyricum Powder Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 15. Global Clostridium Butyricum Powder Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Clostridium Butyricum Powder Sales Volume Market Share in 2024
 Figure 17. Global Clostridium Butyricum Powder Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Single Clostridium Butyricum Powder Revenue Market Share by Manufacturer in 2024
 Figure 20. Compound Clostridium Butyricum Powder Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Clostridium Butyricum Powder Sales Market Share by Type (2020-2031)
 Figure 22. Global Clostridium Butyricum Powder Revenue Market Share by Type (2020-2031)
 Figure 23. Global Clostridium Butyricum Powder Sales Market Share by Application (2020-2031)
 Figure 24. Global Clostridium Butyricum Powder Revenue Market Share by Application (2020-2031)
 Figure 25. North America Clostridium Butyricum Powder Sales YoY (2020-2031) & (K Units)
 Figure 26. North America Clostridium Butyricum Powder Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Clostridium Butyricum Powder Sales Revenue (US$ Million) in 2024
 Figure 28. North America Clostridium Butyricum Powder Sales Volume (K Units) by Type (2020- 2031)
 Figure 29. North America Clostridium Butyricum Powder Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Clostridium Butyricum Powder Sales Volume (K Units) by Application (2020-2031)
 Figure 31. North America Clostridium Butyricum Powder Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Clostridium Butyricum Powder Sales YoY (2020-2031) & (K Units)
 Figure 36. Europe Clostridium Butyricum Powder Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Clostridium Butyricum Powder Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Clostridium Butyricum Powder Sales Volume (K Units) by Type (2020-2031)
 Figure 39. Europe Clostridium Butyricum Powder Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Clostridium Butyricum Powder Sales Volume (K Units) by Application (2020-2031)
 Figure 41. Europe Clostridium Butyricum Powder Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 43. France Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Clostridium Butyricum Powder Sales YoY (2020-2031) & (K Units)
 Figure 48. Asia-Pacific Clostridium Butyricum Powder Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Clostridium Butyricum Powder Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Clostridium Butyricum Powder Sales Volume (K Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Clostridium Butyricum Powder Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Clostridium Butyricum Powder Sales Volume (K Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Clostridium Butyricum Powder Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 58. India Clostridium Butyricum Powder Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Clostridium Butyricum Powder Sales YoY (2020-2031) & (K Units)
 Figure 60. Central and South America Clostridium Butyricum Powder Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Clostridium Butyricum Powder Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Clostridium Butyricum Powder Sales Volume (K Units) by Type (2021-2031)
 Figure 63. Central and South America Clostridium Butyricum Powder Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Clostridium Butyricum Powder Sales Volume (K Units) by Application (2020-2031)
 Figure 65. Central and South America Clostridium Butyricum Powder Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Clostridium Butyricum Powder Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Clostridium Butyricum Powder Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Clostridium Butyricum Powder Sales YoY (2020-2031) & (K Units)
 Figure 69. Middle East and Africa Clostridium Butyricum Powder Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Clostridium Butyricum Powder Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Clostridium Butyricum Powder Sales Volume (K Units) by Type (2021-2031)
 Figure 72. South America Clostridium Butyricum Powder Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Clostridium Butyricum Powder Sales Volume (K Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Clostridium Butyricum Powder Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Clostridium Butyricum Powder Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Clostridium Butyricum Powder Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Clostridium Butyricum Powder Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Clostridium Butyricum Powder Revenue (2020-2025) & (US$ Million)
 Figure 79. Clostridium Butyricum Powder Industry Chain Mapping
 Figure 80. Regional Clostridium Butyricum Powder Manufacturing Base Distribution (%)
 Figure 81. Global Clostridium Butyricum Powder Production Market Share by Region (2020-2031)
 Figure 82. Clostridium Butyricum Powder Production Process
 Figure 83. Regional Clostridium Butyricum Powder Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Epigenetic Analysis Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Y20100
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Blood DNA Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-31J19847
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Pancreatic Enzyme Functional Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33U19833
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Plant Genetic Engineering Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26Y19619
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions